Target intelligence / Profile preview

RE1-silencing transcription factor (REST) (REST)

Target
REST
Molecular classification
Transcription factor, Zinc finger protein, Repressor, Epigenetic regulator
01

Overview

The RE1-silencing transcription factor (REST), also known as the neuron-restrictive silencer factor (NRSF), is a master transcriptional repressor that plays a pivotal role in neurogenesis and the maintenance of neuronal identity. It functions by binding to a specific 21-base pair DNA sequence known as the repressor element 1 (RE1) or neuron-restrictive silencer element (NRSE), where it recruits a variety of co-repressor complexes, including CoREST and mSin3, to induce epigenetic modifications such as histone deacetylation and methylation (NIH, 2016; Wikipedia, 2024). While REST is highly expressed in non-neuronal tissues and neural stem cells to silence neuronal genes, its downregulation is essential for the differentiation of neurons (MDPI, 2023). Dysregulation of the REST/NRSF complex is implicated in a wide range of pathologies, including neurodegenerative diseases like Huntington's and Alzheimer's, where aberrant nuclear localization or loss of function contributes to neuronal death (AlzDiscovery, 2021). In oncology, REST acts as a context-dependent oncogene or tumor suppressor; for instance, it is overexpressed in medulloblastoma and glioma but often lost in neuroendocrine tumors like small cell lung cancer (NIH, 2019). Therapeutic strategies targeting the REST/NRSF complex include small molecules that induce its degradation, mimetics that block its interaction with co-repressors, and inhibitors of its associated enzymatic components like HDACs and LSD1 (Protein Science, 2017).

Other names
Neuron-restrictive silencer factorNRSFX2 box repressorXBRREST4GINGF5HGF5DFNA27
02

Mechanism of action

Inhibition of REST-DNA binding, induction of REST degradation, or inhibition of associated co-repressors (HDACs, LSD1) to restore or modulate target gene expression.

03

Biological functions

NeurogenesisGene silencingNeuronal differentiationSynaptic plasticityOxidative stress resistanceMaintenance of neuronal viability
04

Disease associations

CancerNeurodegenerative diseaseEpilepsyStrokeDiabetesInflammation
05

Safety considerations

Pleiotropic effectsGlobal gene expression changesImpact on neurogenesisContext-dependent activity (repressor vs activator)
06

Interacting drugs

SP2509

4 more in the full profile.

07

Biomarkers

REST expression levelsRE1 occupancySynaptophysinChromogranin ABDNF levels

Beyond the preview

Go deeper on RE1-silencing transcription factor (REST) (REST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RE1-silencing transcription factor (REST) (REST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call